Conditional gene expression in the mouse using a Sleeping Beauty gene-trap transposon

Aron M. Geurts, Andrew Wilber, Corey M. Carlson, Paul D. Lobitz, Karl J Clark, Perry B. Hackett, R. Scott McIvor, David A. Largaespada

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Background: Insertional mutagenesis techniques with transposable elements have been popular among geneticists studying model organisms from E. coli to Drosophila and, more recently, the mouse. One such element is the Sleeping Beauty (SB) transposon that has been shown in several studies to be an effective insertional mutagen in the mouse germline. SB transposon vector studies have employed different functional elements and reporter molecules to disrupt and report the expression of endogenous mouse genes. We sought to generate a transposon system that would be capable of reporting the expression pattern of a mouse gene while allowing for conditional expression of a gene of interest in a tissue- or temporal-specific pattern. Results: Here we report the systematic development and testing of a transposon-based gene-trap system incorporating the doxycycline-repressible Tet-Off (tTA) system that is capable of activating the expression of genes under control of a Tet response element (TRE) promoter. We demonstrate that the gene trap system is fully functional in vitro by introducing the "gene-trap tTA" vector into human cells by transposition and identifying clones that activate expression of a TRE-luciferase transgene in a doxycycline-dependent manner. In transgenic mice, we mobilize gene-trap tTA vectors, discover parameters that can affect germline mobilization rates, and identify candidate gene insertions to demonstrate the in vivo functionality of the vector system. We further demonstrate that the gene-trap can act as a reporter of endogenous gene expression and it can be coupled with bioluminescent imaging to identify genes with tissue-specific expression patterns. Conclusion: Akin to the GAL4/UAS system used in the fly, we have made progress developing a tool for mutating and revealing the expression of mouse genes by generating the tTA transactivator in the presence of a secondary TRE-regulated reporter molecule. A vector like the gene-trap tTA could provide a means for both annotating mouse genes and creating a resource of mice that express a regulable transcription factor in temporally- and tissue-specific patterns for conditional gene expression studies. These mice would be a valuable resource to the mouse genetics community for purpose of dissecting mammalian gene function.

Original languageEnglish (US)
Article number30
JournalBMC Biotechnology
Volume6
DOIs
StatePublished - Jun 26 2006
Externally publishedYes

Fingerprint

Beauty
Gene Expression
Genes
Response Elements
Doxycycline
Insertional Mutagenesis
DNA Transposable Elements
Trans-Activators
Mutagens
Luciferases
Transgenes
Reporter Genes
Diptera
Transgenic Mice
Drosophila
Transcription Factors
Clone Cells

ASJC Scopus subject areas

  • Medicine(all)
  • Biotechnology

Cite this

Geurts, A. M., Wilber, A., Carlson, C. M., Lobitz, P. D., Clark, K. J., Hackett, P. B., ... Largaespada, D. A. (2006). Conditional gene expression in the mouse using a Sleeping Beauty gene-trap transposon. BMC Biotechnology, 6, [30]. https://doi.org/10.1186/1472-6750-6-30

Conditional gene expression in the mouse using a Sleeping Beauty gene-trap transposon. / Geurts, Aron M.; Wilber, Andrew; Carlson, Corey M.; Lobitz, Paul D.; Clark, Karl J; Hackett, Perry B.; McIvor, R. Scott; Largaespada, David A.

In: BMC Biotechnology, Vol. 6, 30, 26.06.2006.

Research output: Contribution to journalArticle

Geurts, AM, Wilber, A, Carlson, CM, Lobitz, PD, Clark, KJ, Hackett, PB, McIvor, RS & Largaespada, DA 2006, 'Conditional gene expression in the mouse using a Sleeping Beauty gene-trap transposon', BMC Biotechnology, vol. 6, 30. https://doi.org/10.1186/1472-6750-6-30
Geurts, Aron M. ; Wilber, Andrew ; Carlson, Corey M. ; Lobitz, Paul D. ; Clark, Karl J ; Hackett, Perry B. ; McIvor, R. Scott ; Largaespada, David A. / Conditional gene expression in the mouse using a Sleeping Beauty gene-trap transposon. In: BMC Biotechnology. 2006 ; Vol. 6.
@article{da63bee0cca74d09bd8e82c2b80104aa,
title = "Conditional gene expression in the mouse using a Sleeping Beauty gene-trap transposon",
abstract = "Background: Insertional mutagenesis techniques with transposable elements have been popular among geneticists studying model organisms from E. coli to Drosophila and, more recently, the mouse. One such element is the Sleeping Beauty (SB) transposon that has been shown in several studies to be an effective insertional mutagen in the mouse germline. SB transposon vector studies have employed different functional elements and reporter molecules to disrupt and report the expression of endogenous mouse genes. We sought to generate a transposon system that would be capable of reporting the expression pattern of a mouse gene while allowing for conditional expression of a gene of interest in a tissue- or temporal-specific pattern. Results: Here we report the systematic development and testing of a transposon-based gene-trap system incorporating the doxycycline-repressible Tet-Off (tTA) system that is capable of activating the expression of genes under control of a Tet response element (TRE) promoter. We demonstrate that the gene trap system is fully functional in vitro by introducing the {"}gene-trap tTA{"} vector into human cells by transposition and identifying clones that activate expression of a TRE-luciferase transgene in a doxycycline-dependent manner. In transgenic mice, we mobilize gene-trap tTA vectors, discover parameters that can affect germline mobilization rates, and identify candidate gene insertions to demonstrate the in vivo functionality of the vector system. We further demonstrate that the gene-trap can act as a reporter of endogenous gene expression and it can be coupled with bioluminescent imaging to identify genes with tissue-specific expression patterns. Conclusion: Akin to the GAL4/UAS system used in the fly, we have made progress developing a tool for mutating and revealing the expression of mouse genes by generating the tTA transactivator in the presence of a secondary TRE-regulated reporter molecule. A vector like the gene-trap tTA could provide a means for both annotating mouse genes and creating a resource of mice that express a regulable transcription factor in temporally- and tissue-specific patterns for conditional gene expression studies. These mice would be a valuable resource to the mouse genetics community for purpose of dissecting mammalian gene function.",
author = "Geurts, {Aron M.} and Andrew Wilber and Carlson, {Corey M.} and Lobitz, {Paul D.} and Clark, {Karl J} and Hackett, {Perry B.} and McIvor, {R. Scott} and Largaespada, {David A.}",
year = "2006",
month = "6",
day = "26",
doi = "10.1186/1472-6750-6-30",
language = "English (US)",
volume = "6",
journal = "BMC Biotechnology",
issn = "1472-6750",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Conditional gene expression in the mouse using a Sleeping Beauty gene-trap transposon

AU - Geurts, Aron M.

AU - Wilber, Andrew

AU - Carlson, Corey M.

AU - Lobitz, Paul D.

AU - Clark, Karl J

AU - Hackett, Perry B.

AU - McIvor, R. Scott

AU - Largaespada, David A.

PY - 2006/6/26

Y1 - 2006/6/26

N2 - Background: Insertional mutagenesis techniques with transposable elements have been popular among geneticists studying model organisms from E. coli to Drosophila and, more recently, the mouse. One such element is the Sleeping Beauty (SB) transposon that has been shown in several studies to be an effective insertional mutagen in the mouse germline. SB transposon vector studies have employed different functional elements and reporter molecules to disrupt and report the expression of endogenous mouse genes. We sought to generate a transposon system that would be capable of reporting the expression pattern of a mouse gene while allowing for conditional expression of a gene of interest in a tissue- or temporal-specific pattern. Results: Here we report the systematic development and testing of a transposon-based gene-trap system incorporating the doxycycline-repressible Tet-Off (tTA) system that is capable of activating the expression of genes under control of a Tet response element (TRE) promoter. We demonstrate that the gene trap system is fully functional in vitro by introducing the "gene-trap tTA" vector into human cells by transposition and identifying clones that activate expression of a TRE-luciferase transgene in a doxycycline-dependent manner. In transgenic mice, we mobilize gene-trap tTA vectors, discover parameters that can affect germline mobilization rates, and identify candidate gene insertions to demonstrate the in vivo functionality of the vector system. We further demonstrate that the gene-trap can act as a reporter of endogenous gene expression and it can be coupled with bioluminescent imaging to identify genes with tissue-specific expression patterns. Conclusion: Akin to the GAL4/UAS system used in the fly, we have made progress developing a tool for mutating and revealing the expression of mouse genes by generating the tTA transactivator in the presence of a secondary TRE-regulated reporter molecule. A vector like the gene-trap tTA could provide a means for both annotating mouse genes and creating a resource of mice that express a regulable transcription factor in temporally- and tissue-specific patterns for conditional gene expression studies. These mice would be a valuable resource to the mouse genetics community for purpose of dissecting mammalian gene function.

AB - Background: Insertional mutagenesis techniques with transposable elements have been popular among geneticists studying model organisms from E. coli to Drosophila and, more recently, the mouse. One such element is the Sleeping Beauty (SB) transposon that has been shown in several studies to be an effective insertional mutagen in the mouse germline. SB transposon vector studies have employed different functional elements and reporter molecules to disrupt and report the expression of endogenous mouse genes. We sought to generate a transposon system that would be capable of reporting the expression pattern of a mouse gene while allowing for conditional expression of a gene of interest in a tissue- or temporal-specific pattern. Results: Here we report the systematic development and testing of a transposon-based gene-trap system incorporating the doxycycline-repressible Tet-Off (tTA) system that is capable of activating the expression of genes under control of a Tet response element (TRE) promoter. We demonstrate that the gene trap system is fully functional in vitro by introducing the "gene-trap tTA" vector into human cells by transposition and identifying clones that activate expression of a TRE-luciferase transgene in a doxycycline-dependent manner. In transgenic mice, we mobilize gene-trap tTA vectors, discover parameters that can affect germline mobilization rates, and identify candidate gene insertions to demonstrate the in vivo functionality of the vector system. We further demonstrate that the gene-trap can act as a reporter of endogenous gene expression and it can be coupled with bioluminescent imaging to identify genes with tissue-specific expression patterns. Conclusion: Akin to the GAL4/UAS system used in the fly, we have made progress developing a tool for mutating and revealing the expression of mouse genes by generating the tTA transactivator in the presence of a secondary TRE-regulated reporter molecule. A vector like the gene-trap tTA could provide a means for both annotating mouse genes and creating a resource of mice that express a regulable transcription factor in temporally- and tissue-specific patterns for conditional gene expression studies. These mice would be a valuable resource to the mouse genetics community for purpose of dissecting mammalian gene function.

UR - http://www.scopus.com/inward/record.url?scp=33748186110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748186110&partnerID=8YFLogxK

U2 - 10.1186/1472-6750-6-30

DO - 10.1186/1472-6750-6-30

M3 - Article

C2 - 16800892

AN - SCOPUS:33748186110

VL - 6

JO - BMC Biotechnology

JF - BMC Biotechnology

SN - 1472-6750

M1 - 30

ER -